Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of l-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies.

Molecules (Basel, Switzerland) - 22 Nov 2019

Malaguarnera Michele, Cauli Omar

Abstract excerpt

Carnitine is an amino acid derivative, which plays several important roles in human physiology, in the central nervous system, and for mitochondrial metabolism, in particular. Altered carnitine metabolic routes have been associated with a subgroup of patients with autism spectrum disorders (ASD) and could add to the pathophysiology associated with these disorders. We review the current evidence about the clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autism Spectrum Disorder
Share to Carnitine
Share to Comorbidity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dose-Response Relationship, Drug

Share to Genetic Predisposition to Disease

Share to Randomized Controlled Trials as Topic

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 31766743
DOI: 10.3390/molecules24234262
PMCID: PMC6930613

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of l-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies.PMID 31766743Read ↗

Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted TreatmentsSemantic proximity Read ↗

Pharmacological, non-pharmacological and stem cell therapies for the management of autism spectrum disorders: A focus on human studies.Semantic proximity Read ↗

Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.Semantic proximity Read ↗

Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiomeSemantic proximity Read ↗

Altered markers of mitochondrial function in adults with autism spectrum disorderSemantic proximity Read ↗

Knockout of Tmlhe in mice is not associated with autism spectrum disorder phenotypes or motor dysfunction despite low carnitine levels.Semantic proximity Read ↗

Mitochondrial dysfunction in autism.Semantic proximity Read ↗

Pharmacological Interventions in Autism Spectrum Disorder: A Comprehensive Review of Mechanisms and EfficacySemantic proximity Read ↗

The Gut-Immune-Brain Axis in Autism Spectrum Disorders; A Focus on Amino AcidsSemantic proximity Read ↗

Mitochondrial disease in autism spectrum disorder patients: a cohort analysis.Semantic proximity Read ↗

Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing StudiesSemantic proximity Read ↗

Dietary interventions in children with autism spectrum disorders - an updated review of the research evidence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.